The News Feed


New Drug to Hasten Reversal of Mydriasis After Dilated Exam

Studies found Ryzumvi returned pupils nearly to baseline better than placebo at all time points measured, its developers said in announcing its FDA approval.
September 27, 2023

Report Aims to Simplify Optometric Approach to Diabetic Eye Disease

A task force organized by LKC Technologies shares recommendations on early detection, risk assessment, referral cues and patient education goals.
September 15, 2023

New Scleral Lens ‘Microvault’ Option for Hard-to-fit Eyes

The custom feature generates an area of lift specific to the unique contour of the patient’s sclera, the manufacturer says.
August 25, 2023

Eylea HD 8mg Injection Approved for Wet AMD, DME, DR

The new formulation of the popular drug extends the intervals between treatments even further than the original 2mg did.
August 21, 2023

New GA Drug from Iveric Bio Approved

Clinical trials show Izervay can slow disease progression with as few as six monthly doses.
August 7, 2023

New Spectacle Lens Helps Improve Day, Night Vision for Drivers

Shamir says its latest offering reduces glare, increases contrast sensitivity and expands the horizontal visual field.
August 7, 2023

First Prescription Treatment for Demodex Blepharitis Approved

In clinical trials, Xdemvy was able to significantly reduce or eradicate mite infestation in six weeks and showed some improvement within 15 days.
July 25, 2023

B+L Hydration Boost CL Rehydrating Drops Now Available

The product offers wearers up to eight hours of moisture, the company says.
June 14, 2023

B+L Launches AREDS 2 Vitamin with CoQ10 for Heart Health

The added antioxidant helps to support cell function.
June 13, 2023

Novaliq Cyclosporine DED Drop Receives FDA Approval

Previously called CyclASol, Vevye is a water-free 0.1% solution that helps reduce ocular inflammation in as few as four weeks, the company says.
June 8, 2023